Infection with the SARS-CoV-2 virus causes cardiopulmonary and vascular complications,
ranging in severity. Understanding the pathogenic mechanisms of the novel SARS-CoV2
infection and progression can provide potential novel targets for its prevention and/or
treatment. Virus microbiota reciprocal interactions have been studied in a variety of viral
infections. For example, the integrity of Coronavirus particles can be disrupted by surfactin, a
bacterial surface molecule that targets other viruses, including that of influenza A. In this …